海南灵康制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
163
NMPA:163
Drug Approvals
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20253488
- Approval Date
- Mar 4, 2025
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20253487
- Approval Date
- Mar 4, 2025
NMPA
Hydrotalcite Chewable Tablets
- Product Name
- 铝碳酸镁咀嚼片
- Approval Number
- 国药准字H20103483
- Approval Date
- Aug 16, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20203689
- Approval Date
- Jul 15, 2024
NMPA
Enoxacin Gluconate for Injection
- Product Name
- 瑞羚聚
- Approval Number
- 国药准字H20052212
- Approval Date
- Jul 15, 2024
NMPA
Enoxacin Gluconate for Injection
- Product Name
- 瑞羚聚
- Approval Number
- 国药准字H20052211
- Approval Date
- Jul 15, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20203690
- Approval Date
- Jul 15, 2024
NMPA
Lansoprazole for Injection
- Product Name
- 注射用兰索拉唑
- Approval Number
- 国药准字H20213008
- Approval Date
- Jul 15, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found